A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin

Benzer Materyaller

• A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections
  Yazar:: William O’Riordan, ve diğerleri
  Baskı/Yayın Bilgisi: (2015-01-01)
• Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study
  Yazar:: Pullman, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• 2378. Resolution of Signs and Symptoms (S&S) of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) With Delafloxacin (DLX) IV/Oral Therapy
  Yazar:: Pullman, John, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function
  Yazar:: Hoover, Randall K., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• 2377. Outcomes in Patients With History of Cardiac or Vascular Disease (CV) During Treatment of Acute Bacterial Skin And Skin Structure Infection (ABSSSI) With Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ)
  Yazar:: Oguchi, Godson, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)